No significant effect on symptom resolution and hospitalization rates has been shown by the anti-parasitic drug Ivermectin making it an inadvisable treatment against the coronavirus disease (COVID-19). Ivermectin pills (Photo courtesy of IndiaMart via PNA) In a statement on Monday, Feb. 21, the...
A total of 139 participants have so far been enrolled in the clinical trial on the use of sleep-aid supplement melatonin as adjuvant treatment for coronavirus disease (COVID-19) in patients with pneumonia, the Department of Science and Technology (DOST) said. (Photo by James Yarema on Unsplash) The...
The Philippines is exploring the possible use of medicinal plant “sinta” (Andrographis paniculata) in the prevention and treatment against coronavirus disease (COVID-19), the Department of Science and Technology (DOST) said on Wednesday, Oct. 20. (MANILA BULLETIN FILE PHOTO) DOST-Philippine...
Tawa-tawa (Euphorbia hirta) extract is proving to be an effective adjunctive coronavirus disease (COVID-19) treatment for mild to moderate cases, the Department of Science and Technology (DOST) disclosed. Tawa-tawa (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and Development...
SYDNEY, Australia -- Scientists from a number of Australia's leading infectious disease and antibody therapeutic centers are confident they are a step closer to creating a COVID-19 treatment. Scientists around the world are working on a number of vaccines and treatments for COVID-19. (Xinhua/Zhang...
The country’s eight month-long study on the use of anti-parasitic drug Ivermectin as a treatment for coronavirus disease (COVID-19) is set to begin on Sept. 15, the Department of Science and Technology (DOST) said Friday, Aug. 27. (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and...
The Department of Science and Technology (DOST) is seeking more participants for its ongoing randomized controlled clinical trial on the efficacy and safety of tawa-tawa (Euphorbia hirta) extract as an adjunctive coronavirus disease (COVID-19) treatment for mild to moderate cases. Tawa-tawa (Manila...
The Department of Science and Technology (DOST) said Thursday, Aug. 19, that the changes to clinical trial protocols have delayed the start of the country’s eight month-long study on the use of anti-parasitic drug Ivermectin as a treatment for coronavirus disease (COVID-19) in the country....
